


Ask a doctor about a prescription for EXFORGE 5 mg/160 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Exforge 5mg/80mg film-coated tablets
Exforge 5mg/160mg film-coated tablets
Exforge 10mg/160mg film-coated tablets
amlodipine/valsartan
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Exforge tablets contain two active substances called amlodipine and valsartan. Both substances help to control high blood pressure.
This means that both substances help to prevent the blood vessels from narrowing. As a result, the blood vessels relax and the blood pressure decreases.
Exforge is used to treat high blood pressure in adults whose blood pressure is not adequately controlled with amlodipine or valsartan alone.
Do not take Exforge
Do not take Exforge and inform your doctorif any of the above applies to you.
Warnings and precautions
Consult your doctor before starting to take Exforge:
Your doctor may check your kidney function, blood pressure, and levels of electrolytes (such as potassium) in your blood at regular intervals.
See also the information under the heading “Do not take Exforge”.
Tell your doctor before taking Exforge if any of the above applies to you.
Children and adolescents
Exforge is not recommended for children and adolescents (under 18 years).
Other medicines and Exforge
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. Your doctor may need to change your dose and/or take other precautions. In some cases, you may need to stop taking one of the medicines. This is especially true for the medicines listed below:
Taking Exforge with food and drink
People taking Exforge should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice can lead to an increase in the levels of the active substance amlodipine in the blood, which can cause an unpredictable increase in the blood pressure lowering effect of Exforge.
Pregnancy and breast-feeding
Pregnancy
You should inform your doctor if you are pregnant, think you might be pregnant, or are planning to become pregnant. Your doctor will normally advise you to stop taking Exforge before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine to treat your high blood pressure. Exforge is not recommended during the first 3 months of pregnancy and must not be taken after the third month of pregnancy as it may cause serious harm to your baby when taken after this time.
Breast-feeding
Inform your doctor if you are breast-feeding or about to start breast-feeding. It has been shown that amlodipine passes into breast milk in small amounts. It is not recommended to take Exforge during breast-feeding. Your doctor will decide whether you should continue breast-feeding or take another treatment, especially if your baby is a newborn or premature.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
This medicine may make you feel dizzy. This may affect your ability to concentrate. If you are unsure how this medicine will affect you, do not drive, use machines, or perform other activities that require concentration.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. This will help you to get the best results and reduce the risk of side effects.
The usual dose of Exforge is one tablet per day.
Depending on your response to the treatment, your doctor may suggest a higher or lower dose.
Do not exceed the recommended dose.
Exforge and older people (65 years or older)
Your doctor should exercise caution when increasing the dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
If you take more Exforge than you should
If you have taken too many Exforge tablets, or if someone else has taken your tablets, contact a doctor immediately. Excess fluid can build up in the lungs (pulmonary edema) causing difficulty breathing that can develop up to 24-48 hours after ingestion.
If you forget to take Exforge
If you forget to take this medicine, take it as soon as you remember. Then take the next dose at the usual time. However, if it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for a forgotten dose.
If you stop taking Exforge
Stopping your treatment with Exforge may cause your illness to get worse. Do not stop taking your medicine unless your doctor tells you to.
Like all medicines, Exforge can cause side effects, although not everybody gets them.
Some side effects can be serious and require immediate medical attention:
A few patients have experienced these serious side effects (may affect up to 1 in 1,000 patients).If you notice any of the following, tell your doctor immediately:
Allergic reaction with symptoms such as skin rash, itching, swelling of the face, lips or tongue, difficulty breathing, low blood pressure (feeling of fainting, dizziness).
Other possible side effects of Exforge:
Common(may affect up to 1 in 10 patients):Flu; stuffy nose, sore throat and discomfort when swallowing; headache; swelling in the arms, hands, legs, ankles or feet; tiredness; weakness; redness and warmth of the face and/or neck.
Uncommon(may affect up to 1 in 100 patients):Dizziness; nausea and abdominal pain; dry mouth; drowsiness, tingling or numbness of the hands or feet; vertigo, rapid heartbeat including palpitations; dizziness when standing up; cough; diarrhea; constipation; skin rash, redness of the skin; joint inflammation, back pain; joint pain.
Rare(may affect up to 1 in 1,000 patients):Feeling anxious; ringing in the ears (tinnitus); fainting; increased amount of urine or urgent need to urinate; inability to get or maintain an erection; feeling of heaviness; low blood pressure with symptoms such as dizziness, lightheadedness; excessive sweating; skin rash all over the body, itching, muscle spasms.
Tell your doctor if any of the above affects you seriously.
Side effects reported with amlodipine or valsartan alone and not observed with Exforge or observed with a higher frequency with Exforge:
Amlodipine
Tell your doctor immediately if you experience any of the following serious side effects, which are very rare (may affect up to 1 in 10,000 patients) after taking this medicine:
The following side effects have been reported. If any of these cause problems or last more than a week, consult your doctor.
Common(may affect up to 1 in 10 patients):Dizziness, drowsiness; palpitations (feeling your heartbeat); flushing, swelling of the ankles (edema); abdominal pain, feeling unwell (nausea).
Uncommon(may affect up to 1 in 100 patients):Mood changes, anxiety, depression, drowsiness, tremor, changes in taste, fainting, loss of pain sensation; visual disturbances, impaired vision, ringing in the ears; low blood pressure; runny or stuffy nose caused by inflammation of the nasal mucosa (rhinitis); indigestion, vomiting (nausea); hair loss, increased sweating, itching, skin discoloration; urinary disorders, increased need to urinate at night, increased number of times of urination; inability to get an erection, discomfort or enlargement of the breasts in men, pain, feeling unwell, muscle pain, muscle cramps; weight increase or weight loss.
Rare(may affect up to 1 in 1,000 patients):Confusion.
Very rare(may affect up to 1 in 10,000 patients):Decrease in the number of white blood cells, decrease in blood platelets which may cause easy bruising or bleeding (damage to red blood cells); high blood sugar (hyperglycemia); gum inflammation, abdominal swelling (gastritis); abnormal liver function, liver inflammation (hepatitis), yellowing of the skin (jaundice), increase in liver enzymes which may have an effect on some medical tests; increased muscle tension; inflammation of blood vessels often with skin rash, sensitivity to light; disorders combining stiffness, tremor and/or movement disorders.
Valsartan
Frequency not known(frequency cannot be estimated from the available data):Decrease in the number of red blood cells, fever, sore throat or mouth ulcers due to infection; spontaneous bleeding or bruising; high levels of potassium in the blood; abnormal liver function test results; decreased kidney function and severely decreased kidney function; swelling, mainly of the face and throat; muscle pain; skin rash, purple spots; fever; itching; allergic reaction, blistering skin disease (sign of a disease called bullous dermatitis).
If you experience any of the above, contact your doctor immediately.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister.
Do not store above 30°C.
Store in the original package to protect from moisture.
Do not use Exforge if you notice that the packaging is damaged or shows signs of tampering.
Composition ofExforge
Exforge 5mg/80mg film-coated tablets
The active substances of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 5 mg of amlodipine and 80 mg of valsartan.
The other ingredients are microcrystalline cellulose; crospovidone (type A); colloidal anhydrous silica; magnesium stearate; hypromellose (substitution type 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).
Exforge 5mg/160mg film-coated tablets
The active substances of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 5 mg of amlodipine and 160 mg of valsartan.
The other ingredients are microcrystalline cellulose, crospovidone (type A); colloidal anhydrous silica; magnesium stearate; hypromellose (substitution type 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172).
Exforge 10mg/160mg film-coated tablets
The active substances of Exforge are amlodipine (as amlodipine besylate) and valsartan. Each tablet contains 10 mg of amlodipine and 160 mg of valsartan.
The other ingredients are microcrystalline cellulose, crospovidone (type A), colloidal anhydrous silica; magnesium stearate; hypromellose (substitution type 2910 (3 mPa.s)); macrogol 4000; talc, titanium dioxide (E171); yellow iron oxide (E172), red iron oxide (E172).
Appearance and Package Contents
Exforge 5 mg/80 mg tablets are round and dark yellow in color with «NVR» on one side and «NV» on the other side. Approximate size: diameter 8.20 mm.
Exforge 5 mg/160 mg tablets are oval and dark yellow in color with «NVR» on one side and «ECE» on the other side. Approximate size: 14.2 mm (length) x 5.7 mm (width).
Exforge 10 mg/160 mg tablets are oval and light yellow in color with «NVR» on one side and «UIC» on the other side. Approximate size: 14.2 mm (length) x 5.7 mm (width).
Exforge is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks containing 4 packs, each with 70 tablets, or 20 packs, each with 14 tablets. All packs are available with standard blisters; the packs of 56, 98 and 280 tablets are also available with perforated unit dose blisters.
Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Farma S.p.A.
Via Proviniciale Schito 131
80058 Torre Annunziata (NA)
Italy
Novartis Farmacéutica SA
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
For further information, please contact the local representative of the Marketing Authorisation Holder:
Belgium/Belgique/Belgien Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania UAB „Novartis Baltics“ Lietuvos filialas Tel: +370 5 269 16 50 |
Bulgaria Novartis Bulgaria EOOD Tel: +359 2 976 98 28 | Luxembourg/Luxemburg Novartis Pharma N.V. Tel: +32 2 246 16 11 |
Czech Republic Novartis s.r.o. Tel: +420 225 775 111 | Hungary Novartis Hungária Kft. Tel: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Tel: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Germany Novartis Pharma GmbH Tel: +49 911 273 0 | Netherlands Novartis Pharma B.V. Tel: +31 26 37 82 111 |
Estonia Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norway Novartis Norge AS Tel: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Novartis Pharma GmbH Tel: +43 1 86 6570 |
Spain Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Poland Novartis Poland Sp. z o.o. Tel: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tel: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Tel: +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Finland Novartis Finland Oy Tel: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Tel: +357 22 690 690 | Sweden Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvia SIA “Novartis Baltics” Tel: +371 67 887 070 | United Kingdom(Northern Ireland) Novartis Ireland Limited Tel: +44 1276 698370 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for EXFORGE 5 mg/160 mg FILM-COATED TABLETS – subject to medical assessment and local rules.